Results 191 to 200 of about 4,931,245 (245)

Preclinical human models of primary ciliary dyskinesia. [PDF]

Eur Respir Rev
Ong JWY, Jackson CL, Arbi M, Hart SL, Mill P, Paff T, Rubbo B, Shahaj E, Shoemark A, Lucas JS.   +9 more
europepmc   +1 more source

Drug-induced dyskinesia--an electrophysiological analysis of dyskinesia induced by L-DOPA and anticholinergic drugs.

Nagoya journal of medical science, 1973
openaire   +2 more sources

Distinct contributions of two subpopulations of subthalamic neurons to levodopa-induced dyskinesia. [PDF]

Sci Adv
Shen B, Han L, Xiao Y, Shen C, Le Z, Wu B, Su L, Yu W, Sun Y, Liu F, Yao H, Wu J, Wang J.   +12 more
europepmc   +1 more source

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications. [PDF]

Front Neurol
Bhidayasiri R, Suansanae T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia

Drugs, 2016
Dyskinesias encompass a variety of different hyperkinetic phenomenologies, particularly chorea, dystonia, stereotypies, and akathisia. Levodopa-induced dyskinesia (LID) is one of the main types of drug-induced dyskinesia, occurring in patients with Parkinson's disease (PD) who have been treated with levodopa for long time, but this side effect may be ...
Subhashie Wijemanne
exaly   +3 more sources

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

Schizophrenia Research, 1991
Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents. The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of
Daniel E Casey, D E Casey
exaly   +3 more sources

Neuroradiological Covariates of Drug-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenia

International Journal of Neuroscience, 1991
Computed tomographic (CT) studies have demonstrated structural brain abnormalities including cortical atrophy and enlarged lateral ventricles in a subset of schizophrenic patients including those with abnormal involuntary movements. In the following series of studies, we present our findings pertaining to neuroradiological covariates of drug-induced ...
Stanley R Kay, S R Kay, R Sandyk
exaly   +3 more sources

The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice

Journal of Neural Transmission, 2012
Drug-induced dyskinesia is a major complication of dopamine replacement therapy in advanced Parkinson's disease consisting of dystonia, chorea and athetosis.
Florian Wegner
exaly   +2 more sources